Additionally, T-cells isolated from psoriasis patients, treated with recombinant PVR ex-vivo, were similarly suppressed as evidenced by a decrease in CD4+ T-cell proliferation and reduction in pro-inflammatory cytokine output15. Here, CD4 is linked to psoriasis.